Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase by Freitas, Mariana et al.
FEBS Open Bio 2 (2012) 119–128journal homepage: www.elsevier .com/locate / febsopenbioOxidative stress adaptation in aggressive prostate cancer may be counteracted
by the reduction of glutathione reductase
Mariana Freitas a,b,c,⇑,1, Inês Baldeiras c,d,1,2, Teresa Proença c,d,1,2, Vera Alves e,3, Anabela Mota-Pinto a,b,1,
Ana Sarmento-Ribeiro b,c,f,1,4
aGeneral Pathology Laboratory, Faculty of Medicine, University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal
bCIMAGO – Centre of Investigation in Environment, Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, Apartado, 9015 3001-301 Coimbra, Portugal
cCNC – Centre of Neurosciences and Cell Biology, Department of Zoology, University of Coimbra, 3004-517 Coimbra, Portugal
d Laboratory of Neurochemistry, Neurology Department, Hospital of the University of Coimbra, Praceta Prof Mota Pinto, 3000-075 Coimbra, Portugal
e Immunology Laboratory, Faculty of Medicine, University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal
fApplied Molecular Biology/Biochemistry Laboratory and Haematology, Faculty of Medicine, University of Coimbra, Subunidade I de Ensino, Pólo III, 3000-354 Coimbra, Portugal
a r t i c l e i n f o a b s t r a c tArticle history:
Received 16 March 2012
Revised 10 May 2012
Accepted 11 May 2012
Keywords:
Prostate cancer
Oxidative stress (OS)
Reactive oxygen species (ROS)
Glutathione (GSH)
Glutathione reductase (Gl-Red)
Cell line2211-5463/$36.00  2012 Federation of European Bio
http://dx.doi.org/10.1016/j.fob.2012.05.001
⇑ Corresponding author at: General Pathology Lab
University of Coimbra, Rua Larga, 3004-504 Coimbra
547.
E-mail addresses: freitas.mariana@gmail.com (M
sapo.pt (I. Baldeiras), teresaproenca@huc.min-saude.p
uc.pt (V. Alves), apinto@fmed.uc.pt (A. Mota-Pinto), a
(A. Sarmento-Ribeiro).
1 Fax: +351 239 721 478.
2 Fax: +351 239 823 907.
3 Fax: +351 239 820 242.
4 Fax: +351 239 480 048.Oxidative stress has been associated with prostate cancer development and progression due to an
increase of reactive oxygen species (ROS). However, the mechanisms whereby ROS and the antioxi-
dant system participate in cancer progression remain unclear.
In order to clarify the influence of oxidative stress in prostate cancer progression, we performed this
study in two human prostate cancer cell lines, PC3 and HPV10 (from metastasis and from localized
cancer, respectively) and RWPE1 cells derived from normal prostate epithelium. Cells were treated
with hydrogen peroxide (H2O2) and PC3 cells were also treated with diethyl maleate (DEM). The
effect on cell growth, viability, mitochondria membrane potential and oxidative stress was analysed.
Oxidative stress was evaluated based on ROS production, oxidative lesion of lipids (MDA) and on
determination of antioxidants, including enzyme activity of glutathione peroxidase (Gl-Px), gluta-
thione reductase (Gl-Red) and on the quantification of glutathione (GSH), glutathione-s-transferase
(GST) and total antioxidant status (TAS).
PC3 shows higher ROS production but also the highest GSH levels and Gl-Red activity, possibly con-
tributing to oxidative stress resistance. This is also associated with higher mitochondrial membrane
potential, TAS and lower lipid peroxidation. On the other hand, we identified Gl-Red activity reduc-
tion as a new strategy in overcoming oxidative stress resistance, by inducing H2O2 cytotoxicity.
Therefore these results suggest Gl-Red activity reduction as a new potential therapeutic approach,
in prostate cancer.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Prostate cancer is still the most frequently diagnosed malignant
disease and the second leading cause of cancer-related mortality in
men in most Western countries [1,2].chemical Societies. Published by E
oratory, Faculty of Medicine,
, Portugal. Fax: 351 239 822
. Freitas), ines.baldeiras@
t (T. Proença), valves@fmed.
na.belasarmento@gmail.comAlthough the causes of the high incidence of prostate cancer are
poorly understood, epidemiological, experimental and clinical
studies, suggest that oxidative stress (OS) plays a major role in
explaining prostate cancer development and progression [3–12].
OS, defined as an imbalance between reactive oxygen species
(ROS) production and antioxidant defences [13,14] has been linked
to some prostate cancer risk factors including diet intake [15–18],
recurrent inflammation and ageing [19–21].
ROS, generated in vivo, include free radicals and non-radicals.
Free radicals are molecules containing unpaired electrons as super-
oxide anion (O2 ), hydroxyl radical (
OH) and peroxide radicals
[22]. Non-radicals such as singlet molecular oxygen (O2), nitrogen
oxide (NOx) and hydrogen peroxide (H2O2) can easily give rise to
oxygen radicals. Namely, H2O2 leads to OH formation, in the pres-
ence of transition metals [22,23]. ROS play an essential role in sig-
nal transduction pathways [24], cell cycle progression [25–30],
gene transcription [31], cell differentiation [28,32] and death (forlsevier B.V. All rights reserved.
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ROS production and/or a decrease in antioxidant network may in-
duce to severe OS leading to biomolecules damage such as DNA,
proteins and lipids [3–12,34,35]. On the other hand, oxidative
damage of DNA is thought to play a critical role in all stages of car-
cinogenesis [36].
Moreover, the major feature of radiation therapy that is a stan-
dard treatment of prostate cancer is based in ROS generation lead-
ing to oxidative damage [37]. However, metastatic prostate cancer
cells may be resistant to radiotherapy, suggesting that the antiox-
idant system may play an important role in circumventing radia-
tion cytotoxicity [34], thus, contributing for therapy failure.
Therefore new therapeutic approaches related, in part, with OS
modulation, have been suggested, namely, by Freitas et al. [38].
The antioxidant network comprises the enzymes superoxide
dismutase (SOD), catalase, glutathione peroxidase (Gl-Px), gluta-
thione reductase (Gl-Red) and glutathione-s-transferase (GST) that
play an important role in prostate cancer prevention, protecting
cells from genomic damage mediated by carcinogens and ROS gen-
erated during inflammation. Other molecules, as vitamins E and C
and reduced glutathione (GSH) complement the antioxidant en-
zymes and are capable of neutralizing ROS [22]. GSH plays a critical
role in cellular redox maintenance. Gl-Px catalyses the reduction of
peroxides and the formation of oxidized glutathione (GSSG) [7]. Gl-
Red uses NADPH and H+ to reduce the GSSG back to GSH [9]. This
paper investigates whether ROS (peroxides) and antioxidant de-
fences contribute to prostate cancer progression and how the OS
modulation may be a new prostate cancer therapeutic approach.
2. Materials and methods
2.1. Cell culture conditions
Human prostate cancer cell lines derived from localized adeno-
carcinoma, from (HPV10) [39], from bone metastasis (PC3) [40]
and from the normal prostate epithelium (RWPE1) [41] were pur-
chased from the American Type Culture Collection (ATCC) and cul-
tured in optimum growth conditions.
RWPE1 and HPV10 cells were grown in keratinocytes medium
(Gibco) supplemented with 5 ng/ml of human recombinant epider-
mal growth factor (rEGF) (Gibco) and 0.05 mg/ml of bovine pitui-
tary extract (BPE) (Invitrogen, formely Gibco-BRL). PC3 cells were
grown in RPMI 1640 medium (Sigma) with 10% (v/v) heat-inacti-
vated fetal bovine serum (FBS) (Biochrom) and 2 mM L-glutamine
(Sigma). Both medium, were supplemented with 100 U/ml Penicil-
lin, 100 lg/ml Streptomycin and with 5 lg/ml Kanamycin (Sigma).
Cells were maintained in a 95% humidified incubator with 5%
CO2 at 37 C and were passaged with trypsinization every fourth
day. For assays RWPE1 and HPV10 were plated at a density of
5  105 cells/ml whereas PC3 were seeded at a density of
3  105 cells/ml. After being cultured for 24 h, the cells were
washed once with fresh assay medium and treated for 24–72 h
with hydrogen peroxide (H2O2) (10 nM–500 lM). PC3 were also
treated with diethyl maleate (DEM) (Sigma).
2.2. Cell proliferation analysis
Cell proliferation was measured by the colorimetric MTT
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide)
(Sigma) assay method that quantifies the reduction of the yellow
tetrazolium salt to purple formazan crystals by the mitochondria
of viable cells [42]. Briefly, untreated and treated cells were
washed with PBS (Gibco) that was replaced by MTT (0.5 mg/ml)
supplemented with 1 mM CaCl2 (Sigma). The cells were then incu-
bated at 37 C for 2 h. Formazan crystals were dissolved with HCl0.04 M in isopropanol. Absorbance from the resultant coloured
solution was measured at 570 nm [38].
2.3. Flow cytometry studies
Each 24 h of incubation, 1  106 of treated cells and correspond-
ing controls, were collected by trypsinization and washed two
times in PBS buffer, by centrifugation, for further acquisition and
analysis in a FACScalibur (488 and 635 nm), using the Cellquest
and Paint-a-gate software (BD Bioscience). Attached cells are con-
sidered as viable and were selected for mitochondrial membrane
potential (MMP) and ROS analysis. For cell viability and death anal-
ysis we also collected the suspension cells.
Specimens were prepared in triplicate and at least 10000 events
were collected.
2.3.1. Cell viability and death: detection of apoptosis or necrosis using
Annexin-V/propidium iodide incorporation
For identification of cell death by apoptosis or necrosis, suspen-
sion and attached cells were collected for the assay. After washed,
the collected cells (1  105) were resuspended in 100 ll of binding
buffer (0.025 M CaCl2, 1.4 M NaCl, 0.1 M Hepes) containing 5 ll
Annexin-V APC and 2 ll propidium iodide 3 lM (PI) (Invitrogen-
Molecular Probes). Samples were kept in the dark at room temper-
ature for 15 min, according to manufacturer’s instruction [43] and
Freitas et al. [38].
2.3.2. Mitochondrial membrane potential (MMP) analysis
In order to detect MMP, the cells were labelled with the
fluorescent probe 5,50,6,60-tethrachloro-1,103,30-tetraethylbenzim-
idazolylcarbocyanine iodide (JC1) (Cell Technology) according to
manufacturer’s instructions as previously performed by Freitas
et al. [38]. Briefly 5  105 cells were resuspended in 0.5 ml of
1 JC-1 reagent solution and then incubated for 15 min, at
37 C in a 5% CO2 chamber. The cells were washed two times
with 2 ml 1 assay buffer under centrifugation at 1500 rpm,
resuspended in 0.5 ml 1 assay buffer and were analysed by
flow cytometry.
The lipophilic cationic probe JC1, developed by Cossariza et al.
[44] is able to selectively enter in the intact mitochondria, forming
J-aggregates (J-A), which are associated with a large shift in emis-
sion (590 nm). However, in lower polarized mitochondrial mem-
brane, JC1 accumulates in the cytoplasm in the monomeric form
(J-M), emitting at 527 nm after excitation at 490 nm. Therefore
the ratio J-M/J-A is inversely correlated with MMP.
2.4. OS evaluation
OS was evaluated by measuring ROS production, antioxidant
capacity and lipid peroxidation.
2.4.1. Reactive oxygen species measurements
We evaluate ROS levels by labelling 5  105 cells with 5 lM 2,7-
dichlorodihydrofluorescein diacetate (DCFH2-DA) (Sigma) accord-
ing to adaptations of previously procedures [38,45–47]. The cells
were incubated during 1 h at 37 C, in the dark, washed two times
in 0.5 ml phosphate-buffered saline (PBS) and were collected
through centrifugation at 1500 rpm. The cells were then resus-
pended in 0.5 ml PBS for flow cytometry analyses. This methodol-
ogy is based on the conversion of (DCFH2-DA) in DCFH2 by
intracellular esterases and consequent formation of the highly
fluorescent 2,7-dichlorofluorescein (DCF) by ROS. The resultant
green fluorescence is proportional to the intracellular level of
ROS, upon excitation at 488 nm. Moreover total population was
considered for ROS measurements.
Fig. 1. Dose–response curves. The effect of different H2O2 concentrations (10 nM–
500 lM) on proliferation of human normal prostate epithelium (RWPE1) and
prostate cancer cells, derived from localized and metastatic carcinoma (HPV10 and
PC3) are represented. Proliferation was evaluated through the formation of
formazan products by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT), each 24 h, during 72 h of incubation, as refereed in materials and
methods. Results are expressed as percentage of MTT reduction relatively to control
(cells not treated with H2O2) and correspond to the mean ± S.D. of at least three
separate experiments.
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2.4.2.1. Cell lysates preparation. After 24 h, treated cells were
washed two times with PBS, scraped off the flasks and resuspended
in 1 ml PBS. Cells were then subjected to three pulses of sonication
for 10 s with 1 min intermittent cooling on ice in a Bandelin
Sonorex.
Protein concentration was assessed using bicinchonic acid assay
kit (Sigma) according to manufacturer’s instruction. The lysates
had been stored at 80 C before usage.
2.4.2.2. Reduced glutathione assay. Reduced glutathione (GSH) was
performed using a kit from Oxisresearch according to manufac-
turer’s instructions. This method is based on the formation of a
chromophoric thione that is proportional to GSH concentration at
420 nm [48]. Results are expressed as lmol of GSH per gram of
protein (lmol/g prot).
2.4.2.3. Antioxidant enzymes determinations.
2.4.2.3.1. Glutathione peroxidase. Glutathione peroxidase (Gl-Px)
activity was evaluated by spectrophotometry using tert-butylper-
oxide as a substrate [49], monitoring the formation of oxidized glu-
tathione, through the quantification of the oxidation of NADPH to
NADP+ at 340 nm. Results are expressed in international units of
enzyme per gram of protein (U/g prot).
2.4.2.3.2. Glutathione reductase. Glutahtione reductase (Gl-Red)
activity was determined using GSSG as a substrate and monitoring
its reduction to GSH through quantification of NADPH oxidation at
340 nm [50] in a thermostatized spectrophotometer UVIKON 933
UV/Visible, at 37 C. Gl-Red activity was expressed in international
units of enzyme per gram of protein (U/g prot)
2.4.2.3.3. Glutathione-s-transferase. Glutathione-s-transferase
(GST) levels, namely from the Pi subgroup (GST-Pi), were quanti-
fied by an Enzyme Immuno Assay (EIA) according to manufac-
turer’s instructions (Immunodiagnostick) at 450 nm. This method
is based in the competition of GST samples and GST from plate
for a rabbit antibody binding. After a washing step, the detection
of the bound rabbit antibody is performed by a peroxidase labelled
goat antibody anti rabbit (POD-antibody). The amount of con-
verted substrate (TMB) is indirectly proportional to the amount
of GST antigen in the sample [51]. The results are expressed as
lmol of GST per gram of protein (lmol/g prot).
2.4.3. Lipid peroxidation evaluation
Oxidative lesion of lipids was evaluated by the formation of a
thiobarbituric acid (TBA) adduct of malondialdehyde (MDA) and
then separated by HPLC [52,53]. Cell lysates were boiled during
60 min with TBA and phosphoric acid, then were deproteinized
with methanol/NaOH 1 M (10:1) and centrifuged. The supernatant
(20 ll) was injected into a Spherisorb ODS2 5 lm (250  4.6 mm)
column. Elution was performed with 60% (v/v) potassium phos-
phate buffer 50 mM, pH 6.8, and 40% (v/v) methanol at a flow rate
of 1 ml/min. The TBA-MDA adducts were detected at 532 nm and
quantified by extrapolating the area of the peaks from a calibration
curve of 1,1,3,3-tetraetoxipropane (TEP) standard solutions. Re-
sults are expressed as lmol of MDA per gram of protein (lmol/g
prot).
2.4.4. Total antioxidant status (TAS) determination
TAS was determined by a chromogenic method (Randox Labora-
tories Crumham’s, North Ireland) with briefly adaptations. This
methodology is based on the capacity to inhibit the formation of
the ABTS+ radical cation (2,20-azino-di-[3-etilbenzotiazolin
sulphonate]) and detection at 600 nm in a spectrophotometer
UVIKON 933-UV/Visible, thermostatized and computerized [54].
Results are expressed as lmol of TAS per gram of protein
(lmol/g prot).2.5. Statistics
Statistical analyses were carried out using t-tests. Significance
was assessed for P values <0.05.
3. Results
3.1. Metastatic prostate cancer cells are more resistant to H2O2 then
the other cell lines3.1.1. Effect of H2O2 on cell growth and viability
Fig. 1 represents the proliferative effect of H2O2 (10 nM–
500 lM) on a cell line derived from human normal prostate epithe-
lium (RWPE1) and on prostate cancer cells, derived from localized
and metastatic carcinoma (HPV10 and PC3, respectively), during
72 h. As we observe H2O2 induces different effects according to cell
type, time of incubation and concentration exposure. Therefore
H2O2 inhibits RWPE1 cell growth for all tested concentrations
whereas PC3 seems to maintain a cell proliferation rate above
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hand we found that low H2O2 concentrations induce an increase
in HPV10 cells proliferation.
We observed that the effect of H2O2 on cell proliferation inhibi-
tion, namely at IC50 concentration is associated to cell death
mainly by necrosis, in HPV10 and RWPE1 cells. Data not shown,
also indicate that lower ROS concentration, namely 100 lM H2O2,
induced necrosis in RWPE1 and HPV10. However, PC3 maintain
cell viability besides a decrease in cell proliferation (Fig. 2). These
results suggest a more efficient adaptation to peroxides in PC3.
3.1.2. Influence of H2O2 on MMP
To evaluate the role of mitochondria on prostate cancer pro-
gression/metastasization and the effect of H2O2 on MMP we used
the JC1 assay. Fig. 3 shows that PC3 cells had the highest basal
MMP and RWPE the lowest, which is in line with viability and pro-
liferative results. However, in the presence of H2O2, we observe aFig. 2. Effect of H2O2 on cell viability and death in RWPE1, HPV10 and PC3 cells. Dot-plot
in the absence (untreated) or in the presence of 500 lM H2O2 during 24 h. Cells were
exclude propidium iodide and do not bind Annexin-V. Apoptotic cells with intact membr
plasma membrane and therefore bind Annexin-V (IA) emitting fluorescence. Propidium
Results were expressed as the percentage of cells staining with the respective molecular p
Significantly viability and necrosis differences are considered: ⁄⁄⁄P < 0.001 vs untreated sasignificant decrease in MMP, in RWPE1 and HPV10 cells, as demon-
strated by the increase of monomers/aggregates (M/A) ratio that
also agree with viability and proliferative results.
3.1.3. Metastatic prostate cancer cells are resistant to ROS (peroxides)
by an increase in GSH content and Gl-Red activity
To evaluate the role of H2O2 on ROS (peroxides) production we
used the 2,7-dichlorodihydrofluorescein diacetate (DCFH2-DA)
probe, a dye that fluoresces in the presence of peroxides (H2O2)
[46].
This study shows that prostate cancer cells, particularly the
metastatic cells (PC3), exhibit significant higher ROS levels com-
pared with the others (Fig. 4). On the other hand the sensitivity
to cytotoxicity induced by ROS (H2O2) in RWPE1 and HPV10 is con-
firmed by an increase in lipid peroxidation as observed in Fig. 5. In
opposite, we found a decrease in lipid peroxidation and increase of
TAS in PC3 (Fig. 5). These results suggest that PC3 cells are resistantprofiles (1) were obtained after the acquisition of 10000 events. Cells were cultured
incubated with Annexin-V/IP as refereed in materials and methods. Alive cells (A)
anes exclude propidium iodide, externalize phosphatidylserine to the outside of the
iodide stains nuclear DNA of necrotic (N) and late apoptosis/necrosis cells (LA/N).
robe (2). The results represent the means ± S.D. of at least triplicate determinations.
mples, ###P < 0.001 for PC3 and HPV10 vs RWPE1 and +++P < 0.001 for PC3 vs HPV10.
Fig. 3. MMP evaluation in RWPE1, HPV10 and PC3 cells. Dot-plot profiles (1) were obtained after the acquisition of 10000 events. RWPE1, HPV10 and PC3 cells were cultured
in the absence (untreated) or in the presence of 500 lMH2O2 for 24 h. The MMPwas assessed by flow cytometry labelling the cells with the molecular probes JC1 as described
in materials and methods. Results were expressed as the ratio of Monomers/Aggregates (M/A) (which are inversely proportional to MMP) and represent the means
MMP ± S.D. of at least triplicate determinations (2). Significantly viability differences are considered: ⁄⁄⁄P < 0.001 vs untreated samples, ###P < 0.001 and ##P < 0.01 for PC3
and HPV10 vs RWPE1 and +P < 0.05 for PC3 vs HPV10.
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lated with prostate progression and metastasization. In order to
determine the contribution of the antioxidant system in cells adap-
tation to ROS, we analysed GSH and GST content and Gl-Red and
Gl-Px activities, simultaneously in the three cell lines. Results rep-
resented in Fig. 6 indicate a significant decrease in GST (Fig. 6D)
content and Gl-Px (Fig. 6B) activity in the malignant cells, particu-
larly in PC3, which may be related with higher H2O2 levels. On the
other hand, PC3 have the highest GSH content and Gl-Red activity
that could contribute to resistance to OS (Fig. 6C and A,
respectively).
3.1.4. Adaptation to peroxides (ROS) is reverted by DEM
In order to evaluate the modulation of ROS resistance by GSH
content, the major thiol in mammalian cells, and Gl-Red activity,
PC3 cells were treated with a thiol depleting agent (DEM), during
24 h.
As we can observe in Fig. 7A1 and A2, DEM induces a decrease
in GSH content and Gl-Red activity concomitantly with a decreasein cell proliferation (Fig. 7B1) and an increase of cytotoxicity med-
iated by H2O2 (ROS) in PC3 cells (Fig. 7C).
In fact, the association of DEM and 500 lM H2O2 induced a de-
crease in cell growth (Fig. 7B2) and viability (Fig. 7C).when com-
pared with 500 lM H2O2 alone. This is accompanied by an
increase in cell death mainly by apoptosis and late apoptosis/
necrosis after 24 h treatment with DEM (Fig. 7C).
4. Discussion
Development of efficient therapies requires a better understand-
ing of the mechanisms underlying prostate carcinogenesis.
Although OS has been associated with prostate cancer development
and progression due to an increase of ROS [7,55], the mechanisms
whereby ROS and antioxidants may induce cancer progression re-
main unclear [12]. As a result, greater understanding of OS may
be of considerable importance for fighting prostate cancer.
In line with existing literature, we observed that the effect of
H2O2 on cell proliferation is dose, time and cell type dependent.
Fig. 4. Effect of H2O2 on ROS production in RWPE1, HPV10 and PC3 cells. Dot-plot profiles (1) were obtained after the acquisition of 10000 events. RWPE1, HPV10 and PC3
cells were cultured in the absence (untreated) or in the presence of 500 lM H2O2 for 24 h. ROS was assessed by flow cytometry labelling the cells with 2,7-
dichlorodihydrofluorescein diacetate (DCFH2-DA). The results were expressed as the means intensity fluorescence (MIF) ± S.D. of at least triplicate determinations (2).
Significantly differences are considered: ⁄P < 0.05 vs untreated samples, ##P < 0.01, ###P < 0.001 for PC3 and HPV10 vs RWPE1 and +++P < 0.001 for PC3 vs HPV10.
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in HPV10, derived from localized carcinoma, suggesting that small
increments of ROS may be important in progression of prostate
cancer. Interestingly, Sikka et al. [7] previously demonstrated that
low levels of H2O2 (30 pM–300 nM), induce cell growth on benign
prostate hyperplasia (BPH), characterized by an intense cell prolif-
eration rate and considered as potential precursor of prostate can-
cer [56]. On the other hand, chronic inflammation of prostate
epithelium, due to persistent ROS production, has been associated
with increase of OS and DNA damage leading to neoplastic trans-
formation (for a good review of this literature see Nelson et al.
[19]). However, an excess of ROS is expected to be harmful and
to induce apoptosis in several human tumour cell lines [19]. Here
we found that 500 lM H2O2 inhibits cell proliferation in all thetested cell lines, but the effect was less pronounced in PC3. These
differences may be notably observed after 72 h of treatment.
Moreover it was accompanied by cell death, essentially by
necrosis, in HPV10 and in the normal epithelium cell line, RWPE1
just after 24 h treatment. Similar results were found by Sikka
et al. [7] in BPH cell lines with 300 lM H2O2. However, higher
H2O2 concentrations did not affect PC3 viability that appears to
be more resistant to OS. It would be interesting to evaluate
whether H2O2 causes some cycle phase-specific blockade, since
drug-provoked oxidative stress causes cell cycle disruption as well
as cell death. This may also be important in cancer treatment.
We observed the highest basal levels of ROS in PC3 (Fig. 4)
which may be related to cells resistance to H2O2 induced cytotox-
icity and to a more aggressive phenotype, although others have
Fig. 5. Evaluation of lipid peroxidation and TAS in RWPE1, HPV10 and PC3 cells. Cells were treated with 500 lM H2O2 for 24 h as described in materials and methods. Lipid
peroxidation (A) was evaluated by MDA determination levels. MDA and TAS (B) levels were detected according with described in material and methods. Results were
expressed as the means ± S.D. of at least triplicate determinations. Significantly differences are considered: ⁄P < 0.05 vs untreated samples, #P < 0.05, ##P < 0.01, ###P < 0.001
for HPV10 and PC3 vs RWPE1 and +P < 0.05, ++P < 0.01 for PC3 vs HPV10.
Fig. 6. Antioxidant defences in RWPE1, HPV10 and PC3 cells. We evaluate Gl-Red (A) and Gl-Px (B) activities and GSH (C) and GST (D) content. Cells were treated with 500 lM
H2O2 for 24 h as described in materials and methods. Results are expressed as the means ± S.D. of at least triplicate determinations. Significantly differences are considered for
⁄P < 0.05, ⁄⁄P < 0.01 vs untreated samples, #P < 0.05, ##P < 0.01, and ###P < 0.001 for HPV10 and PC3 vs RWPE1 and +P < 0.05 and +++P < 0.001 for PC3 vs HPV10.
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oxidative damage of biomolecules such as DNA, proteins and lipids
[3–12,34,35]. It is also important to realize that tumour progres-
sion is based on DNA mutations which promote cancer cells prolif-
eration and surveillance [57]. In part, these mutations may beacquired as a result of an increase of ROS which require an antiox-
idant system adaptation [58].
Viability results are in line with MMP detected in cells. In fact,
at basal conditions, PC3 cells show the highest MMP whereas
RWPE1 cells show the lowest MMP. These results may be related
Fig. 7. Effect of DEM on PC3 antioxidant defences – relation with cell proliferation and viability. GSH content (A1) and Gl-Red activity (A2) on PC3 were analysed after treating
cells with 50 lMDEM for 24 h. The effect of DEM (50 lM–1000 lM) alone (B1) and combined with 500 lMH2O2 (B2) on PC3 cells growth was evaluated during 72 h. In (C) is
represented the influence of DEM on PC3 cell viability and death. Cells were treated with 500 lM H2O2, in the absence (control) and in the presence of 50 lM DEM for 24 h.
Viability was assessed by flow cytometry as previously described. Viable cells are expressed by alive cells (A), initial apoptosis by (IA), necrosis (N) and late by apoptosis/
necrosis (LA/N). Results were expressed as the means ± S.D. of at least triplicate determinations. Significant differences are considered for ⁄P < 0.05, ⁄⁄P < 0.01 and ⁄⁄⁄P < 0.005
vs control. Cell viability and death statistical results are indicated for (IA) and (LA/N).
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way, when PC3 were treated with 500 lMH2O2 we did not observe
a significant decrease in MMP, in contrast to other cell lines. Based
on this evidence we also suggest that variation in MMP is related to
cell growth but not in a directly proportional ratio.
In order to better understand the effect of OS in prostate cancer
progression we evaluated the levels of ROS and antioxidant de-
fences among the distinct cell lines. We found that ROS levels are
lower in RWPE1 and substantially higher in PC3 as we have previ-
ously referred. These findings are in agreementwith those observed
by Kumar et al. [55]. The same authors show that the degree of ROS
generation is directly proportional to aggressive phenotype. They
also found higher levels of ROS in PC3 compared to RWPE1,
although, they did not analyse localized prostate cancer cell lines
as performed in our work. Likewise we demonstrate that HPV10cells show intermediate ROS levels. These cells also represent an
intermediate stage (localized cancer) betweenRWPE1 and PC3 cells.
Kumar et al. [55] also demonstrated that ROS, mainly generated by
the Nox system (trans-membrane proteins called the NADPH oxi-
dases), is essential for deregulated growth, colony formation, cell
migration and invasion and contribute to tumour metastasization.
Besides the increase of ROS levels in PC3 cells, we found lower levels
of MDA and higher levels of TAS that are consistent with cell resis-
tance to OS. Therefore, these results suggest that PC3 cells counter-
act OS by expressing particular free radical scavengers. In fact, we
found significant increase of GSH and Gl-Red activity in PC3 that
may protect these cells under persistent ROS (peroxides) produc-
tion, induced by radiotherapy and chemotherapy. H2O2 treatment
induced a clear decrease in TAS that is in agreement with the in-
crease of MDA. These observations may be due to the absence of a
M. Freitas et al. / FEBS Open Bio 2 (2012) 119–128 127significant increase in the antioxidant defences, in face of the H2O2
insult. On the other hand it may be explained by the high basal lev-
els of GSH content and Gl-Red activity observed in PC3. However,
we may consider other explanations for the observed decrease of
TAS and increase of MDA. Namely, as TAS evaluation is based on
the antioxidants capacity to inhibit ABTS+ radical cation (2,20-azi-
no-di-[3-etilbenzotiazolin sulphonate]) [42] and that the antioxi-
dant system may be recruited to face the increase of H2O2, we
admit that the antioxidant defences are unavailable to inhibit
ABTS+, leading to TAS reduction observations. Moreover, the antiox-
idant system comprises other antioxidant defences like catalase,
playing an important role in neutralizing H2O2, or superoxide dis-
mutase and a-tocopherol (that protects from lipid peroxidation),
which we did not analysed and may also contribute to explain the
decrease of TAS and increase of MDA.
In contrast, Gl-Px activity and GST are depleted in PC3 suggest-
ing that GST depletion may facilitate prostate cancer progression
as described by others [8]. The same assumption may be addressed
to Gl-Px activity.
GSH, the major thiol in mammalian cells, maintains an opti-
mum cellular redox potential trough the inactivation of H2O2.
The contribution of GSH and Gl-Red in PC3 cells protection against
ROS was also suggested by Lim et al. [9]. These authors compared
two metastatic prostate cancer cells, LNCaP, and PC3 and found
lower ROS levels in PC3 that could be explained by an increase of
GSH content, Gl-Red, thioredoxin reductase (TR) and GST activities.
However, Kumar et al. [55] contradict those results showing higher
ROS levels in PC3 comparing to LNCaP. In our study, PC3 Gl-Red
activity is in the range values found by Jung et al. [3]. These authors
also reported an increase in Gl-Red and a decrease in GST and Gl-Px
activities in metastatic prostate cancer cells (PC3, LNCaP and
DU145) comparing with primary cell cultures of benign and malig-
nant human prostatic tissue. They also show higher Gl-Px and low-
er Gl-Red activities in PC3 cells comparing to other metastatic cell
lines, reinforcing our observations that Gl-Px is decreased and Gl-
Red is increased in advanced tumours cells. Therefore Gl-Red may
contribute to protection against ROS.
To confirm the role of GSH content and Gl-Red activity in the
adaptation to OS by metastatic prostate cancer cells, we treat the
cells with DEM, a thiol depletion agent. Our study revealed that
cells treated with 50 lM DEM alone show a decrease in Gl-Red
activity, additionally to a decrease in GSH content (Fig. 7A1) with
no interference on cell proliferation and death. However, in the
presence of H2O2 the decrease in Gl-Red activity and GSH content
was accomplished by a decrease in cell proliferation and increase
of cell death preferentially by apoptosis and late apoptosis/necro-
sis. GSH reduction in the presence of DEM is in agreement with
the results obtained by Coffey et al. [59,60]. These authors show
an increase of apoptosis induced by radiation, in the presence of
DEM, in PC3 and in other metastatic prostate cancer cells, LNCaP
and DU145. They also found that apoptosis is accompanied by an
efflux of GSH from the nucleus to the cytosol and admit that the
presence of GSH in the nucleus may offer resistance to apoptosis.
Here we strongly proved that Gl-Red activity reduction partici-
pates in the increase of H2O2 toxicity in metastatic prostate cancer
cells, suggesting a potential therapeutic approach. It may be also
related with GSH reduction as observed here and by others
[59,60]. These results also conduct to the possibility of using other
Gl-Red activity reducing agents or to evaluate the combined effect
of DEM with conventional chemotherapeutic drugs, namely doce-
taxel, expecting that the association may allow to lowering drug
concentrations, therefore reducing drug side effects, related with
systemic toxicity. In fact we previously found that sodium selenite,
a thiol depleting agent, combined with docetaxel, play a synergistic
effect on PC3 cells growth inhibition and induces cell death [38]
Likewise our study warrants further evaluation of OS modulationin prostate cancer therapeutic approach. In particular, it would
be interesting to evaluate the effect of DEM-produced GSH deple-
tion and Gl-Red reduced activity in the RWPE cells, in order to eval-
uate the potential toxicity in non-tumour cells.
5. Conclusions
As described above, other reports have compared the relative
efficacy of antioxidant system in prostate cancer. However, this
work develops a more graded study by including models represen-
tative of different stages of prostate malignancy.
To our knowledge, our study performed on cell lines repre-
senting normal prostate epithelium, localized and metastatic
prostate cancer, all stages of prostate cancer progression, is the
first demonstrating an increase of ROS (peroxides) along with
prostate cancer progression, concomitantly with OS adaptation.
Therefore we suggest that this duality may be necessary for pros-
tate cancer progression and for a more aggressive malignant phe-
notype. On the other hand, as normal epithelium cell line shows
lower ROS levels in basal conditions, but greater sensitivity to
cytotoxicity induced by ROS (500 lM H2O2) and concomitantly
lower GSH levels and Gl-Red activity, these conditions may con-
tribute to a higher susceptibility to OS lesion by normal prostate
epithelium.
The cell line model, presented here shows an important ap-
proach to understanding OS through the different stages of pros-
tate cancer. However, it is possible that cell lines do not exactly
reflect the true in vivo situation. We also realize that the present
strategy, developed in a cell line model, may not be efficient when
applied to in vivo experiments. Different culture conditions could
influence the observed results. However, this study does propose
OS modulation as a possible new therapeutic approach in prostate
cancer. We intend to carry out further evaluation of this strategy to
in vivo model.
Furthermore, as far as we are aware, we are the first to confirm
the pivotal role of GI-Red’s activity as a new target-directed thera-
peutic tool in the treatment of prostate cancer.
Acknowledgements and funding
This work was supported by the CIMAGO – Centre of Investiga-
tion in Environment, Genetics and Oncobiology, Faculty of Medi-
cine, University of Coimbra [Grants CIMAGO 14/05, CIMAGO 3/
06] and the Fundação para a Ciência e a Tecnologia (FCT), Portugal
[Grant SFRH/BD/40215/2007].
References
[1] Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M.J. (2008)
Cancer statistics 2008. CA Cancer J. Clin. 587, 71–96.
[2] Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer statistics 2010. CA Cancer
J. Clin. 60 (5), 277–300.
[3] Jung, K., Seidel, B., Rudolph, B., Lein, M., Cronauer, M.V., Henke, W., Hampel, G.,
Schnorr, D. and Loening, S.A. (1997) Antioxidant enzymes in malignant
prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med.
23, 127–133.
[4] Baker, A.M., Oberley, L.W. and Cohen, M.B. (1997) Expression of antioxidant
enzymes in human prostatic adenocarcinomas. Prostate 32, 229–233.
[5] Oberley, T.D., Zhong, W., Szweda, L.I. and Oberley, L.W. (2000) Localization of
antioxidant enzymes and oxidative damage products in normal and malignant
prostate epithelium. Prostate 44, 144–155.
[6] Bostwick, D.G., Alexander, E.E., Singh, R., Shan, A., Qian, J., Santella, R.M.,
Oberley, L.W., Yan, T., Zhong, W., Jiang, X. and Oberley, T.D. (2000) Antioxidant
enzyme expression and reactive oxygen species damage in prostatic
intraepithelial neoplasia and cancer. Cancer 89, 123–134.
[7] Sikka, S.C. (2003) Role of oxidative stress response elements and antioxidants
in prostate cancer pathobiology and chemoprevention-a mechanistic
approach. Curr. Med. Chem. 10 (24), 2679–2692.
[8] Trzeciak, A.R., Nyaga, S.G., Jaruga, P., Lohani, A., Dizdaroglu, M. and Evans, M.K.
(2004) Cellular repair of oxidatively induced DNA base lesions is defective in
prostate cancer cell lines PC-3 and DU-145. Carcinogenesis 25, 1359–1370.
128 M. Freitas et al. / FEBS Open Bio 2 (2012) 119–128[9] Lim, H.W., Hong, S., Jin, W., Lim, S., Kim, S.J., Kang, H.J., Park, E.H., Ahn, K. and
Lim, C.J. (2005) Up-regulation of defense enzymes is responsible for low
reactive oxygen species in malignant prostate cancer cells. Exp. Mol. Med. 37
(5), 497–506.
[10] Venkataraman, S., Jiang, X., Weydert, C., Zhang, Y., Zhang, H.J., Goswami, P.C.,
Ritchie, J.M., Oberley, L.W. and Buettner, G.R. (2005) Manganese superoxide
dismutase overexpression inhibits the growth of androgen-independent
prostate cancer cells. Oncogene 24, 77–89.
[11] Aydin, A., Arsova-Sarafinovska, Z., Sayal, A., Eken, A., Erdem, O., Erten, K.,
Ozgök, Y. and Dimovski, A. (2006) Oxidative stress and antioxidant status in
non-metastatic prostate cancer and benign prostatic hyperplasia. Clin.
Biochem. 39, 176–179.
[12] Yossepowitch, O., Pinchuk, I., Gur, U., Neumann, A., Lichtenberg, D. and Baniel,
J. (2007) Advanced but not localized prostate cancer is associated with
increased oxidative stress. J. Urol. 178 (4), 1238–1244.
[13] Sies, H. (1985) Oxidative stress: introductory remarks in: Oxidative Stress
(Sies, H., Ed.), pp. 1–8, Academic Press, London.
[14] Sies, H. (1997) Oxidative stress: oxidants and antioxidants. Exp. Physiol. 82
(2), 291–295.
[15] Shimizu, H., Ross, R.K., Bernstein, L., Yatani, R., Henderson, B.E. and Mack, T.M.
(1991) Cancers of the prostate and breast among Japanese and white
immigrants in Los Angeles County. Br. J. Cancer 63, 963–966.
[16] Whittemore, A.S., Kolonel, L.N., Wu, A.H., John, E.M., Gallagher, R.P., Howe,
G.R., Burch, J.D., Hankin, J., Dreon, D.M., West, D.W., Teh, C.-Z. and
Paffenbarger, R.S. (1995) Prostate cancer in relation to diet physical activity
and body size in blacks whites and Asians in the United States and Canada. J.
Natl. Cancer Inst. 87, 652–661.
[17] Gronberg, H. (2003) Prostate cancer epidemiology. Lancet 361, 859–864.
[18] Jian, L., Xie, P., Lee, A.H. and Binns, C.W. (2004) Protective effect of green tea
against prostate cancer: a case-control study in southeast China. Int. J. Cancer
108, 130–135.
[19] Nelson, W.G., DeWeese, T.L. and DeMarzo, A.M. (2002) The diet inflammation
and the development of prostate cancer. Cancer Metastasis Rev. 21, 3–16.
[20] De Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C.G., Nakai,
Y., Isaacs, W.B. and Nelson, W.G. (2007) Inflammation in prostate
carcinogenesis. Nat. Rev. Cancer 7, 256–269.
[21] Kwabi-Addo, B., Chung, W., Shen, L., Ittmann, M., Wheeler, T., Jelinek, J. and
Issa, J.-P. (2007) Age-related DNA methylation changes in normal human
prostate tissues. Clin. Cancer Res. 13, 3796–3802.
[22] Halliwell, B. and Gutteridge, J.M.C. (1990) Role of free radicals and catalytic
metal ions in human disease: an overview. Methods Enzymol. 186, 1–85.
[23] Aruoma, O.I. (1998) Free radicals oxidants and antioxidants: trend towards the
year 2000 and beyond in: Molecular Biology of Free Radicals in Human
Diseases (Aruoma, O.I. and Halliwell, B., Eds.), pp. 1–28, OICA International, St.
Lucia, London.
[24] Sundaresan, M., Yu, Z.X., Ferrans, V.J., Irani, K. and Finkel, T. (1995)
Requirement for generation of H2O2 for platelet-derived growth factor signal
transduction. Science 270, 296–299.
[25] Murrell, G.A., Francis, M.J. and Bromley, L. (1990) Modulation of fibroblast
proliferation by oxygen free radicals. Biochem. J. 265 (3), 659–665.
[26] Burdon, R.H. (1995) Superoxide and hydrogen peroxide in relation to
mammalian cell proliferation. Free Radic. Biol. Med. 18, 775–794.
[27] del Bello, B., Paolicchi, A., Comporti, M., Pompella, A. and Maellaro, E. (1999)
Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity
is involved in prevention of apoptosis and maintenance of proliferation in
U937 cells. FASEB J. 13 (1), 69–79.
[28] Sauer, H., Wartenberg, M. and Hescheler, J. (2001) Reactive oxygen species as
intracellular messengers during cell growth and differentiation. Cell. Physiol.
Biochem. 11, 173–186.
[29] Courtney, G., Havens, A.H., Naohisa, Y. and Steven, F.D. (2006) Regulation of
late G1/S phase transition and APCCdh1 by reactive oxygen species. Mol. Cell.
Biol. 26 (12), 4701–4711.
[30] Boonstra, J. and Post, J.A. (2004) Molecular events associated with reactive
oxygen species and cell cycle progression in mammalian cells. Gene 337, 1–13.
[31] Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C. and
Schumacker, P.T. (1998) Mitochondrial reactive oxygen species trigger
hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95, 11715–11720.
[32] Allen, R.G. and Balin, A.K. (1989) Oxidative influence on development and
differentiation: an overview of a free radical theory of development. Free
Radic. Biol. Med. 6 (6), 631–661.
[33] Martindale, J.L. and Holbrook, N.J. (2002) Cellular response to oxidative stress:
signalling for suicide and survival. J. Cell. Physiol. 192, 1–15.
[34] Suzuki, Y., Kondo, Y., Himeno, S., Nemoto, K., Akimoto, M. and Amura, N.
(2000) Role of antioxidant systems in human androgen-independent prostate
cancer cells. Prostate 43, 144–149.[35] Shackelford, R.E., Kaufmann, W.K. and Paules, R.S. (2000) Oxidative stress and
cell cycle checkpoint function. Free Radic. Biol. Med. 28, 1387–1404.
[36] Guyton, K.Z. and Kensler, T.W. (1993) Oxidative mechanisms in
carcinogenesis. Br. Med. Bull. 49 (3), 523–544.
[37] Haimovitz-Friedman, A. (1998) Radiation-induced signal transduction and
stress response. Radiat. Res. 150, 102–108.
[38] Freitas, M., Alves, V., Sarmento-Ribeiro, A.B. and Mota-Pinto, A. (2011)
Combined effect of sodium selenite and docetaxel on PC3 metastatic
prostate cancer cell line. Biochem. Biophys. Res. Commun. 408, 713–719.
[39] Weijerman, P.C., König, J.J., Wong, S.T., Niesters, H.G. and Peehl, D.M. (1994)
Lipofection-mediated immortalization of human prostatic epithelial cells of
normal and malignant origin using human papillomavirus type 18 DNA.
Cancer Res. 54 (21), 5579–5583.
[40] Kaighn, M.E., Narayan, K.S., Ohnuki, Y., Lechner, J.F. and Jones, L.W. (1979)
Establishment and characterization of a human prostatic carcinoma cell line
(PC3). Invest. Urol. 17 (1), 16–23.
[41] Bello, D., Webber, M.M., Kleinman, H.K., Wartinger, D.D. and Rhim, J.S. (1997)
Androgen responsive adult human prostatic epithelial cell lines immortalized
by human papillomavirus 18. Carcinogenesis 18, 1215–1223.
[42] Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L.,
Abbot, B.J., Mayo, J.G., Shoemaker, R.H. and Boyd, M.R. (1998) Feasibility of
drug screening with panels of human tumour cell lines using a microculture
tetrazolium assay. Cancer Res. 48 (3), 589–601.
[43] Boldyrev, A.A. (2000) Discrimination between apoptosis and necrosis of
neurons under oxidative stress. Biochemistry (Mosc.) 65, 834–842.
[44] Cossarizza, A., Baccarini-Contri, M., Kalashnikova, G. and Franceschi, C. (1993)
A new method for the cytofluorimetric analysis of mitochondrial membrane
potential using J-aggregate forming lipophilic cation 5,50 ,6,60-tetrachloro-
1,10 ,3,30-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys.
Res. Commun. 197, 40–45.
[45] Rothe, G. and Valet, G. (1990) Flow cytometric analysis of respiratory burst
activity in phagocytes with hydroethidine and 2,7 dichlorofluorescein. J.
Leukoc. Biol. 47 (5), 440–448.
[46] Lee, H.C., Yin, P.H., Lu, C.Y., Chi, C.W. and Wei, Y.H. (2000) Increase of
mitochondria and mitochondrial DNA in response to oxidative stress in
human cells. Biochem. J. 348, 425–432.
[47] Gao, F., Yi, J., Yuan, J.Q., Shi, G.Y. and Tang, X.M. (2004) The cell cycle related
apoptotic susceptibility to arsenic trioxide is associated with the level of
reactive oxygen species. Cell Res. 14, 81–85.
[48] Tsao, S.-M., Yin, M.-C. and Liu, W.-H. (2007) Oxidant stress and B vitamins
status in patients with non-small cell lung cancer. Nutr. Cancer 59 (1), 8–13.
[49] Plagia, D.E. and Valentine, W.N. (1967) Studies on the quantitative and
qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin.
Med. 70, 158–169.
[50] Goldberg, D.M. and Spooner, R.J. (1983) Glutathione reductase in: Methods in
Enzymatic Analysis (Bergmeryer, U.H., Ed.), pp. 258–265, Verlag Chemie
Weinheim Academic Press, New York.
[51] Kullich, W., Fagerer, N. and Schwann, H. (2007) Effect of the NSAID nimesulide
on the radical scavenger glutathione-S-transferase in patients with
osteoarthritis of the knee. Curr. Med. Res. Opin. 23 (8), 1981–1986.
[52] Knight, J.A., Pieper, R.K. and McClellan, L. (1998) Specificity of the
thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin.
Chem. 34 (12), 2433–2438.
[53] Draper, H.H. and Hadley, M. (1990) Malondialdehyde determination as an
index of lipid peroxidation. Methods Enzymol. 186, 421–431.
[54] Miller, J.K., Brzezinska-Slebodzinska, E. and Madsen, F.C. (1993) Oxidative
stress antioxidants and animal function. J. Dairy Sci. 76, 2812–2823.
[55] Kumar, B., Koul, S., Khandrinka, L., Meacham, R.B. and Koul, H.K. (2008)
Oxidative stress is inherent in prostate cancer cells and is required for
aggressive phenotype. Cancer Res. 68 (6), 1777–1785.
[56] Mishina, T., Watanabe, H., Araki, H. and Nakao, M. (1985) Epidemiological
study of prostatic cancer by matched-pair analysis. Prostate 6, 423–446.
[57] Loeb, K.R. and Loeb, L.A. (2000) Significance of multiple mutations in cancer.
Carcinogenesis 21 (3), 379–385.
[58] Khandrika, L., Kumar, B., Koul, S., Maroni, P. and Koul, H.K. (2009) Oxidative
stress in prostate cancer. Cancer Lett. 282 (2), 125–136.
[59] Coffey, R.N.T., Watson, R.W.G., Hegarty, N.J., O’Neill, A., Gibbons, N., Brady, H.R.
and Fitzpatrick, J.M. (2000) Thiol mediated apoptosis in prostate carcinoma
cells. Cancer 88 (9), 2092–2104.
[60] Coffey, R.N.T., Watson, R.W.G., Hegarty, P.K., Watson, C.L., Woloham, L., Brady,
H.R., O’Keane, C. and Fitzpatrick, J.M. (2001) Priming prostate cancer cells for
increased apoptosis is associated with up-regulation of the caspases. Cancer
92 (9), 2297–2308.
